These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16889454)

  • 1. Preventing depression after stroke: Results from a randomized placebo-controlled trial.
    Almeida OP; Waterreus A; Hankey GJ
    J Clin Psychiatry; 2006 Jul; 67(7):1104-9. PubMed ID: 16889454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
    Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
    Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression.
    Murray V; von Arbin M; Bartfai A; Berggren AL; Landtblom AM; Lundmark J; Näsman P; Olsson JE; Samuelsson M; Terént A; Varelius R; Asberg M; Mårtensson B
    J Clin Psychiatry; 2005 Jun; 66(6):708-16. PubMed ID: 15960563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an older age cohort at risk for depression: study protocol for a randomized controlled trial.
    Cockayne NL; Duffy SL; Bonomally R; English A; Amminger PG; Mackinnon A; Christensen HM; Naismith SL; Hickie IB
    Trials; 2015 Jun; 16():247. PubMed ID: 26037484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.
    Lewis G; Duffy L; Ades A; Amos R; Araya R; Brabyn S; Button KS; Churchill R; Derrick C; Dowrick C; Gilbody S; Fawsitt C; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Khan N; Lanham P; Pervin J; Peters TJ; Riozzie D; Salaminios G; Thomas L; Welton NJ; Wiles N; Woodhouse R; Lewis G
    Lancet Psychiatry; 2019 Nov; 6(11):903-914. PubMed ID: 31543474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB; Stahl SM; Hertzman M; Harrison WM
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial.
    Friedli K; Guirguis A; Almond M; Day C; Chilcot J; Da Silva-Gane M; Davenport A; Fineberg NA; Spencer B; Wellsted D; Farrington K
    Clin J Am Soc Nephrol; 2017 Feb; 12(2):280-286. PubMed ID: 28126706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
    Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B
    Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial.
    Yan N; Hu S
    BMC Psychiatry; 2024 May; 24(1):365. PubMed ID: 38750479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
    Ravindran AV; Guelfi JD; Lane RM; Cassano GB
    J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
    Lyketsos CG; DelCampo L; Steinberg M; Miles Q; Steele CD; Munro C; Baker AS; Sheppard JM; Frangakis C; Brandt J; Rabins PV
    Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder.
    Lépine JP; Caillard V; Bisserbe JC; Troy S; Hotton JM; Boyer P
    Am J Psychiatry; 2004 May; 161(5):836-42. PubMed ID: 15121648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
    Hedayati SS; Gregg LP; Carmody T; Jain N; Toups M; Rush AJ; Toto RD; Trivedi MH
    JAMA; 2017 Nov; 318(19):1876-1890. PubMed ID: 29101402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
    Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ;
    Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
    Schneider LS; Nelson JC; Clary CM; Newhouse P; Krishnan KR; Shiovitz T; Weihs K;
    Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression.
    Hantsoo L; Ward-O'Brien D; Czarkowski KA; Gueorguieva R; Price LH; Epperson CN
    Psychopharmacology (Berl); 2014 Mar; 231(5):939-48. PubMed ID: 24173623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
    Thase ME; Fava M; Halbreich U; Kocsis JH; Koran L; Davidson J; Rosenbaum J; Harrison W
    Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.
    Mulholland C; Lynch G; King DJ; Cooper SJ
    J Psychopharmacol; 2003 Mar; 17(1):107-12. PubMed ID: 12680747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.
    Narushima K; Kosier JT; Robinson RG
    J Nerv Ment Dis; 2002 May; 190(5):296-303. PubMed ID: 12011609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.